X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Epigenomics

期刊標題檢索 EPIGENOMICS-UK 最新評論: How did you answer, thank you? (2023-12-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Epigenomics]您好,您是該頁面的第 46187 位訪客。

期刊簡介
期刊名稱Epigenomics Epigenomics
LetPub Score
7.6
50 ratings
Rate

Reputation
8.8

Influence
6.2

Speed
9.7

期刊簡稱EPIGENOMICS-UK
ISSN1750-1911
E-ISSN1750-192X
h-index44
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.800.7510.475
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Genetics
Q2138 / 347
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q2113 / 230

自引率 (2023-2024)6.70%自引率趨勢
掲載範囲
Epigenomics provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time constrained community.

Substantial developments in our current knowledge and understanding of genomics and epigenetics are constantly being made, yet this field is still in its infancy. Epigenomics provides a critical overview of the latest and most significant advances as they unfold and explores their potential application in the clinical setting.
官方網站http://www.epigenomics.com/en/
在線稿件提交
開放訪問No
出版商Future Medicine Ltd.
主題領域GENETICS & HEREDITY
出版國/地區ENGLAND
發行頻率
創刊年2009
每年文章數93每年文章數趨勢
黃金OA百分比18.68%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
GENETICS & HEREDITYSCIEQ277/191
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1750-1911%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【Epigenomics】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE644492
    BIOMATERIALS595468
    Frontiers in Pharmacology499451
    BIOMEDICINE & PHARMACOTHERAPY498564
    JOURNAL OF ETHNOPHARMACOLOGY489001
    Journal of Materials Chemistry B476136
    Frontiers in Immunology460718
    COLLOIDS AND SURFACES B-BIOINTERFACES419440
    COMPUTERS IN BIOLOGY AND MEDICINE418739
    Frontiers in Oncology415246
  •  

    Epigenomics Epigenomics
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/7)
  [Epigenomics] 的評論撰寫評論
作者: 俊悟小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-06 19:37:42 評論於
How did you answer, thank you?
(0) 讚! | 俊悟小娘子

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-06 23:07:40 評論於
Now it has been repaired
(0) 讚! | 是志丹吖

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-06 22:06:53 評論於
Currently it is possible, but there needs to be a good point of innovation
(0) 讚! | 是志丹吖

作者: 努力啊大树芬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-06 19:58:12 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as headers: 
https://www.futuremedicine.com/journal/epi
(0) 讚! | 努力啊大树芬

作者: 通幽博裕


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-01 18:31:06 評論於
What is the official website of this magazine? When I clicked on it, it seems like a company
(0) 讚! | 通幽博裕

作者: Cynthia Bartholomew


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-24 14:52:07 評論於
How much is the layout fee?
(0) 讚! | Cynthia Bartholomew

作者: 魔都寻梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-30 22:01:26 評論於
Hello, is the expedited publishing fee inclusive of all publishing fees?
(0) 讚! | 魔都寻梅

作者: 千花喜春


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-11 17:11:46 評論於
Do you accept raw data?
(0) 讚! | 千花喜春

作者: 百花永年


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-16 08:06:37 評論於
Does your $3600 include OA fees?
(0) 讚! | 百花永年

作者: 北国银河


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-17 23:22:19 評論於
Have you found it?
(0) 讚! | 北国银河

作者: 碧水新筠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-01 20:59:53 評論於
How are things going?
(0) 讚! | 碧水新筠

作者: 一条小映冬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-17 10:12:00 評論於
Is this journal peer-reviewed by AE first, and then sent for external review if accepted, so the process is slower?
(0) 讚! | 一条小映冬

作者: 是浩然吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-03 10:23:03 評論於
Research focus: Bioinformatics; Experience sharing on tumor: Applied for accelerated review when submitting, but it has been under consideration for 20 days
(0) 讚! | 是浩然吖

作者: 伏魔芷波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-26 18:45:27 評論於
Excuse me, have you sent the reminder behind you? How long does it usually take to receive it?
(0) 讚! | 伏魔芷波

作者: 伏魔芷波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-26 18:43:37 評論於
How are you doing now? It's been 21 days for me and still no external review. Should we remind them?
(0) 讚! | 伏魔芷波

作者: 巴蜀子轩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-24 22:19:12 評論於
Hello, how much does expedited service cost?
(0) 讚! | 巴蜀子轩

作者: 暴风思萌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-20 20:15:30 評論於
It's not an external audit, mine has also been 21 days, and it hasn't been audited yet, so slow
(0) 讚! | 暴风思萌

作者: 暴风思萌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-11 17:31:07 評論於
Did you send it to external review? Or did you withdraw the submission yourself?
(0) 讚! | 暴风思萌

作者: 暴风思萌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-11 16:15:10 評論於
I've been waiting for 24 days and even selected expedited shipping, but it's still so slow. I don't understand why it can't be faster
(0) 讚! | 暴风思萌

作者: 霹雳飞英


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-14 22:51:26 評論於
Please translate the following passage into English and Japanese, and title them as ":" and ":"
(0) 讚! | 霹雳飞英

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:20:05 評論於
Medicine, Scientific Reports, Plos One, Oncology letter, Oncology report, Cell physiol biochem, Biochemical and biophysical research, etc
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:27:28 評論於
Do not submit to newly established magazines with rapidly increasing impact factors; do not submit to journals with few published articles; do not submit to journals from regions with underdeveloped academic communities. Safe journals are those published by larger groups or some high-impact factor magazines
(0) 讚! | 维尔娜菲茨杰拉德

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 12:16:11 評論於
Which journals are recognized as top-tier?
(0) 讚! | Darlene Pepys

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 11:08:11 評論於
What pitfalls should be avoided when selecting publications?
(0) 讚! | 陶宜三岁啦

作者: 狮吼江胜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-16 17:01:18 評論於
Research focus: Bioinformatics
Sharing experience: High rejection rate
(0) 讚! | 狮吼江胜

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/7)

開始撰寫 [Epigenomics] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*